Header Logo

Duc Ha

Concepts (100)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hypertension
8
2026
606
1.260
 Why?
Vietnam
16
2026
183
0.960
 Why?
Rural Population
4
2026
223
0.790
 Why?
Noncommunicable Diseases
2
2019
18
0.740
 Why?
Cardiovascular Diseases
4
2020
858
0.720
 Why?
Cancer Survivors
1
2021
128
0.600
 Why?
Stakeholder Participation
1
2019
29
0.590
 Why?
Lung Neoplasms
1
2021
702
0.440
 Why?
Risk Reduction Behavior
1
2010
121
0.310
 Why?
Life Style
2
2024
320
0.310
 Why?
Primary Prevention
1
2010
136
0.300
 Why?
Prevalence
5
2026
1431
0.290
 Why?
Health Knowledge, Attitudes, Practice
1
2013
767
0.270
 Why?
Community Health Workers
2
2020
41
0.260
 Why?
Cost-Benefit Analysis
3
2020
316
0.250
 Why?
Quality of Life
2
2026
1254
0.250
 Why?
Myocardial Infarction
3
2022
918
0.240
 Why?
Fibrinolytic Agents
1
2026
176
0.220
 Why?
Time-to-Treatment
1
2026
132
0.220
 Why?
Thrombolytic Therapy
1
2026
195
0.220
 Why?
Depression, Postpartum
1
2026
120
0.210
 Why?
Humans
19
2026
64768
0.190
 Why?
Text Messaging
1
2024
97
0.190
 Why?
Adult
8
2026
17251
0.180
 Why?
Developing Countries
2
2019
86
0.180
 Why?
Clinical Laboratory Services
1
2021
5
0.170
 Why?
Medical Laboratory Personnel
1
2021
10
0.170
 Why?
Income
2
2019
169
0.170
 Why?
Air Travel
1
2021
3
0.170
 Why?
Contact Tracing
1
2021
17
0.170
 Why?
Middle Aged
11
2026
18156
0.170
 Why?
ST Elevation Myocardial Infarction
1
2022
95
0.160
 Why?
Data Collection
2
2019
382
0.160
 Why?
Patients
1
2021
114
0.160
 Why?
Surveys and Questionnaires
2
2021
2751
0.160
 Why?
Aged
10
2026
14882
0.150
 Why?
Endovascular Procedures
1
2026
626
0.150
 Why?
Female
13
2026
33804
0.150
 Why?
Smoking Cessation
1
2024
551
0.140
 Why?
Cross-Sectional Studies
2
2026
2690
0.140
 Why?
Male
12
2026
30840
0.140
 Why?
Clinical Trials as Topic
1
2021
460
0.140
 Why?
Hospital Administration
2
2014
43
0.130
 Why?
Pneumonia, Ventilator-Associated
1
2017
36
0.130
 Why?
Randomized Controlled Trials as Topic
1
2020
797
0.120
 Why?
Drug Resistance, Bacterial
1
2017
96
0.120
 Why?
Lung
1
2021
962
0.120
 Why?
Biomedical Research
1
2019
260
0.120
 Why?
Health Behavior
1
2018
482
0.110
 Why?
Patient Education as Topic
1
2018
481
0.110
 Why?
Clinical Protocols
1
2016
134
0.110
 Why?
Health Education
1
2016
188
0.110
 Why?
Intensive Care Units
1
2017
420
0.100
 Why?
Sex Factors
2
2014
986
0.100
 Why?
Comorbidity
2
2014
1097
0.100
 Why?
Treatment Outcome
4
2026
5765
0.100
 Why?
Sex Characteristics
1
2014
210
0.090
 Why?
Aged, 80 and over
4
2021
5590
0.090
 Why?
Overweight
1
2013
255
0.080
 Why?
Anti-Bacterial Agents
1
2017
795
0.080
 Why?
Risk Factors
3
2026
5392
0.080
 Why?
Health Status Indicators
1
2010
94
0.080
 Why?
Hospitalization
2
2014
1380
0.080
 Why?
Age Factors
1
2013
1568
0.070
 Why?
Early Ambulation
1
2026
10
0.060
 Why?
Time Factors
2
2026
3748
0.060
 Why?
Disability Evaluation
1
2026
216
0.050
 Why?
Recovery of Function
1
2026
291
0.050
 Why?
Hotlines
1
2024
21
0.050
 Why?
Blood Pressure
1
2026
521
0.050
 Why?
Peer Group
1
2024
113
0.050
 Why?
Social Support
1
2026
391
0.050
 Why?
Anxiety
1
2026
422
0.050
 Why?
Registries
1
2026
906
0.040
 Why?
Alcohol Drinking
1
2024
321
0.040
 Why?
Shock, Cardiogenic
1
2022
108
0.040
 Why?
Pandemics
1
2026
671
0.040
 Why?
Health Promotion
1
2024
512
0.040
 Why?
Hospitals
1
2022
385
0.040
 Why?
Smoking
1
2024
859
0.040
 Why?
Patient Compliance
1
2021
364
0.040
 Why?
Risk Assessment
1
2026
2090
0.040
 Why?
Hospital Mortality
1
2022
873
0.030
 Why?
Ceftazidime
1
2017
2
0.030
 Why?
Imipenem
1
2017
5
0.030
 Why?
Acinetobacter baumannii
1
2017
7
0.030
 Why?
beta-Lactams
1
2017
11
0.030
 Why?
Acinetobacter Infections
1
2017
7
0.030
 Why?
Klebsiella
1
2017
10
0.030
 Why?
Ciprofloxacin
1
2017
24
0.030
 Why?
Pseudomonas Infections
1
2017
73
0.030
 Why?
Microbial Sensitivity Tests
1
2017
206
0.030
 Why?
Pseudomonas aeruginosa
1
2017
132
0.030
 Why?
Young Adult
1
2026
4772
0.030
 Why?
Culture
1
2016
82
0.030
 Why?
Data Interpretation, Statistical
1
2016
195
0.030
 Why?
Retrospective Studies
1
2026
6818
0.030
 Why?
Follow-Up Studies
1
2018
2473
0.020
 Why?
Pilot Projects
1
2014
1008
0.020
 Why?
Prognosis
1
2014
1772
0.020
 Why?
Ha's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (100)
Explore
_
Co-Authors (12)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_